China-ASEAN Regional Medical Products Trading Platform Surpasses RMB 10 Million in Transaction Volume

Source: Cailian Press

【China-ASEAN Regional Bulk Purchase Platform for Medical Devices Exceeds 10 Million Yuan in Transaction Volume】Cailian Press, January 17 — At today’s seminar on "Chinese Medical Insurance Supporting Chinese Pharmaceuticals and Medical Devices Going Global," the Guangxi Zhuang Autonomous Region Medical Insurance Bureau introduced the role of the China-ASEAN Regional Pharmaceutical Trading (Bulk Purchase) Platform in promoting Chinese pharmaceuticals and medical devices. Currently, the platform's transaction volume for pharmaceuticals and medical devices has exceeded 10 million yuan, including Qilu Pharmaceutical's "Piperacillin Sodium Tazobactam Sodium for Injection."HISUNProducts such as "Irbesartan Tablets" by HISUN, "Bailing Capsules" by Hangzhou Zhongmei Huadong, and others cover multiple countries in Southeast Asia. In terms of medical devices, an order for the procurement of "Holmium Laser Treatment Equipment" was completed between Vietnam's HFM TRADING COMPANY LIMITED and Guangzhou Potent Medical Equipment Joint-stock Inc. The platform has already assisted 16 enterprises with the registration and listing of 53 medical devices in Vietnam. (Reporters Wang Junxian and Lu Afeng from Cailian Press)